ADL
TXG icon

Asset Dedication LLC’s 10x Genomics TXG Stock Holding History

Asset Dedication LLC’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51
Closed -$1.08K – 1281
2026
Q1 		$1.08K Hold
51
– – ﹤0.01% 1016
2025
Q4 		$832 Hold
51
– – ﹤0.01% 1063
2025
Q3 		$597 Hold
51
– – ﹤0.01% 1091
2025
Q2 		$591 Hold
51
– – ﹤0.01% 1119
2025
Q1 		$446 Hold
51
– – ﹤0.01% 1064
2024
Q4 		$733 Hold
51
– – ﹤0.01% 1028
2024
Q3 		$1.15K Hold
51
– – ﹤0.01% 1055
2024
Q2 		$992 Buy
+51
New +$1.33K ﹤0.01% 1101
2022
Q2 		– Sell
-27
Closed -$2K – 958
2022
Q1 		$2K Hold
27
– – ﹤0.01% 885
2021
Q4 		$4K Hold
27
– – ﹤0.01% 783
2021
Q3 		$4K Buy
+27
New +$4.64K ﹤0.01% 840

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Asset Dedication LLC's TXG Position: Q2 2026 in Review

Asset Dedication LLC sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 51 shares — an estimated $1.08K sold.

Asset Dedication LLC first reported a position in TXG in Q3 2021 and held it in 11 quarters. The position peaked at $4K in Q4 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Asset Dedication LLC reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Asset Dedication LLC sold 51 10x Genomics shares in Q2 2026, an estimated $1.08K.
  • Asset Dedication LLC first reported a position in 10x Genomics in Q3 2021 and held it in 11 quarters.
  • Asset Dedication LLC's 10x Genomics position peaked at $4K in Q4 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.